URGN R&D Expense Growth
Urogen Pharma Ltd · R&D Expense Growth
URGN R&D Expense Growth
Latest reported17.43%period ending
URGN FY R&D Growth (YoY) (0.00% → 17.43%)
Latest values, visible window
High-resolution chart · PNG
URGN r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 17.4328% | |
| 25.2795% | |
| -13.7829% | |
| 11.0491% | |
| 0.7018% | |
| -4.0307% | |
| 33.4732% | |
| 97.5397% | |
| 81.7537% | |
| -2.1683% | |
| 162.3503% | |
| 71.7224% | |
| 0% |